U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

U.S. President Donald Trump, Eli Lilly (LLY.N) and Novo Nordisk (NOVOb.CO) signed a deal in November to slash the prices of ...

Some Medicare enrollees may soon be able to access super-popular drugs for obesity under a voluntary model program, the Centers for Medicare and Medicaid Services announced Tuesday. Eligible ...

The next transformative phase of weight-loss medication is upon us, with the US Food and Drug Administration (FDA) approving ...

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

The best time to take berberine may be with or just before meals when using it for weight loss and blood sugar control.

Exciting new findings indicate that GLP-1 weight-loss medications might dramatically reduce the likelihood of 10 types of ...

Eli Lilly and Company, along with partner institutions in the US and United Kingdom, describe how short-term pharmacologic intervention does not appear to have lasting effects for most tirzepatide ...

Twelve and 1 participants taking metformin attempted suicide once and twice, respectively, compared with 25 and 3, respectively, among those not taking metformin. HealthDay News — The benefits of ...

Metformin plus LIFE intervention vs LIFE intervention alone resulted in greater changes in BMI in youth with bipolar disorder. HealthDay News — The benefits of metformin outweigh the risks for young ...

FRIDAY, Nov. 21, 2025 (HealthDay News) -- The benefits of metformin outweigh the risks for young people with bipolar spectrum disorder who have overweight or obesity and are treated with ...